- ►shouxi.net T Okada, J Wada, K Hida, J Eguchi, I … - Diabetes, 2006 - Am Diabetes Assoc Thiazolidinediones are ligands for peroxisome proliferator–activated receptor
(PPAR)-γ, widely used as insulin sensitizer in type 2 diabetic patients and
implicated in apoptosis, cell proliferation, and cell cycle regulation. ... Cited by 25 - Related articles - BL Direct - All 5 versions
- ►physiology.org [PDF] S Ohga, K Shikata, K Yozai, S Okada, D … - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc Page 1. Ohga et al., Page 1 Original Article Thiazolidinedione ameliorates
renal injury in experimental diabetic rats through anti ... Cited by 39 - Related articles - BL Direct - All 8 versions
CW Park, Y Zhang, X Zhang, J Wu, L Chen, DR … - Kidney International, 2006 - nature.com Peroxisome proliferator-activated receptor (PPAR ) is a member of the
ligand-activated nuclear receptor superfamily, and plays an important role in
lipid metabolism and glucose homeostasis. The purpose of this study is to ... Cited by 39 - Related articles - BL Direct - All 3 versions
P Balakumar, VA Chakkarwar, P Krishan, M … - Biomedicine & Pharmacotherapy, 2009 - Elsevier Vascular endothelium regulates vascular tone and maintains free flow of blood in
vessels. Vascular endothelial dysfunction (VED) results in reduced activation of
endothelial nitric oxide synthase (eNOS), reduced generation and ... Cited by 9 - Related articles - All 2 versions
- ►physiology.org [PDF] Y Zhang, X Zhang, L Chen, J Wu, D Su, WJ Lu … - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc 37 articles, 22 of which you can access free at: This article cites
http://ajprenal.physiology.org/cgi/content/full/290/5/F1065#BIBL ... 2 other
HighWire hosted articles: This article has been cited by Cited by 10 - Related articles - All 5 versions
T Kanjanabuch, LJ Ma, J Chen, A Pozzi, Y … - Kidney International, 2007 - nature.com Podocyte injury and loss contribute to progressive glomerulosclerosis.
Peroxisome proliferator-activated receptor- (PPAR- ) is a nuclear hormone
receptor, which we have found to be increased in podocytes in a variety of ... Cited by 23 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org CW Park, HW Kim, SH Ko, HW Chung, SW Lim … - Diabetes, 2006 - Am Diabetes Assoc Peroxisome proliferator–activated receptor (PPAR)α, a member of the
ligand-activated nuclear receptor superfamily, plays an important role in lipid
metabolism and glucose homeostasis and is highly expressed in the kidney. ... Cited by 34 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org AC Calkin, S Giunti, KA Jandeleit-Dahm, TJ … - Nephrology Dialysis Transplantation, 2006 - ERA-EDTA Backgound. Peroxisome proliferator-activated receptor (PPAR)- and PPAR- agonists
are widely used in diabetes. In addition to their effects on lipid and glucose
homeostasis, these agents have been postulated to have independent ... Cited by 27 - Related articles - BL Direct - All 6 versions
- ►problemsinanes.com AB Fogo - Current Opinion in Nephrology and Hypertension, 2008 - journals.lww.com Purpose of review: The thiazolidinediones are agonists for peroxisome
proliferator-activated receptor-γ, and promote insulin sensitization and
improve dyslipidemia in patients with type II diabetes mellitus. Peroxisome ... Cited by 1 - Related articles - BL Direct - All 5 versions
DR Cha, X Zhang, Y Zhang, J Wu, D Su, JY … - Diabetes, 2007 - Am Diabetes Assoc Peroxisome proliferator–activated receptors (PPARs) are nuclear transcription
factors and play a central role in insulin sensitivity, lipid metabolism, and
inflammation. Both PPARα and -γ are expressed in the kidney, and their ... Cited by 17 - Related articles - BL Direct - All 4 versions
